This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Individuals infected with COVID-19 are also at an increased risk of suffering from heartrhythm disturbances, such as atrialfibrillation, according to a new study.
Research Highlights: An analysis of health data in the UK Biobank found a 20% higher risk of irregular heartrhythm, known as atrialfibrillation, among people who said they drank two liters or more per week (about 67 ounces) of artificially sweetened.
Atrialfibrillation (AFib) is a common heartrhythm disorder characterized by an irregular and often rapid heartbeat. This condition can lead to various complications, including stroke and heart failure, making it essential to understand its causes, symptoms, and AFib treatment options. What is AtrialFibrillation?
Researchers have developed an AI tool that creates synthetic yet medically accurate models of fibrotic heart tissue (heart scarring), aiding treatment planning for atrialfibrillation (AF) patients. The study could lead to more personalized care for patients affected by this common heartrhythm disorder.
Researchers from Queen Mary University of London have developed an AI tool that creates synthetic yet medically accurate models of fibrotic heart tissue (heart scarring), aiding treatment planning for atrialfibrillation (AF) patients.
Wearable, long-term continuous heart monitors helped identify 52% more cases of atrialfibrillation compared to usual care, but that did not lead to a reduction in hospitalizations due to stroke, according to a new study.
Individuals infected with COVID-19 are also at an increased risk of suffering from heartrhythm disturbances, such as atrialfibrillation. This is shown in a new study published in European Heart Journal Open by researchers from Umeå University, Sweden, in one of the largest studies of its kind in the world.
Based on continuous monitoring of early recurrence of atrial tachyarrhythmia immediately after patients have undergone atrialfibrillation ablation, Musat et al. recommend shortening the blanking period from three months to one. Lead author Jonathan M. also emphasize the importance of continuous monitoring.
Research Highlights: Treating gum disease within three months after a heart procedure to correct an irregular heartrhythm, known as atrialfibrillation (AFib), may lower the chances of it reoccurring. Inflamed gums may predict AFib recurrence after.
The HeartRhythm Society (HRS) is preparing for HRX 2024, the third annual event of its kind, which will be held from September 5-7, 2024, in Atlanta, GA, gathering cardiovascular health innovators together to explore discoveries and advance partnerships between medicine and technology. Avari Silva On Saturday, Sept.
a medical device company dedicated to advancing ablation treatment for cardiac arrythmias, announced its participation at the HeartRhythm 2024 conference, taking place in person at the Boston Convention & Exhibition Center and virtually, May 16-19, 2024. EDT, in Rhythm Theater #2.
Atrialfibrillation, or AFib, is a fast and irregular heartrhythm that, left untreated, can lead to blood clots, stroke and heart failure. It's the most common type of arrhythmia, a potentially serious condition in which the heart beats too quickly, too slowly or in an irregular pattern.
An elevated heart rate could provide an important clue to which Black adults often have a dangerous heartrhythm disorder, a new study finds. Higher resting heart rate is associated with increased risk of atrialfibrillation, researchers found.
Outcomes of ablation with the FARAPULSE PFA System – a nonthermal treatment in which electric fields selectively ablate heart tissue – will be compared to outcomes following use of anti-arrhythmic drug (AAD) therapy, which is commonly prescribed for patients living with persistent AF. Circulation.
milla1cf Thu, 01/18/2024 - 14:21 January 18, 2024 — Abbott announced the first global procedures have been conducted using the company's new Volt Pulsed Field Ablation (PFA) System to treat patients battling common abnormal heartrhythms such as atrialfibrillation (AFib).
Work-related stress caused by job strain and an imbalance between efforts applied vs. rewards received may increase the risk of developing atrialfibrillation, according to new research published in the Journal of the American Heart Association.
A new study by researchers at the University of Arizona College of Medicine–Phoenix and the University of California Davis Health identified a new target for developing a therapy to treat atrialfibrillation, the most common type of abnormal heartrhythm.
People taking medical cannabis for chronic pain have a slightly increased risk of arrhythmia, according to research published in the European Heart Journal today (Thursday). Arrhythmia is when the heart beats too slowly, too quickly or irregularly. It includes conditions like atrialfibrillation.
A 240-year-old drug called digoxin could save the National Health Service (NHS) at least 100 million each year when treating older patients with atrialfibrillation and heart failure.
In patients with symptoms such as irregular heartbeats, dizziness, or fainting, or in individuals that physicians suspect may have atrialfibrillation, many days of ECGs may be required for diagnosis"long-term ECG recordings."
Treating gum disease in the three months after a procedure to correct an irregular heartbeat known as atrialfibrillation (AFib) may lower oral inflammation and may reduce AFib recurrence, according to new research published today in the Journal of the American Heart Association.
AFib is the most common heartrhythm disorder, affecting more than 30 million patients worldwide. No consensus currently exists regarding the optimal treatment of persistent AFib patients. By guiding ablation therapy, [EGF mapping] can enable clinicians to provide personalized, highly targeted treatment."
tim.hodson Mon, 03/03/2025 - 16:26 March 1, 202 One in three people worldwide will develop a potentially life-threatening heartrhythm disorder in their lifetime, yet awareness remains critically low. While some heartrhythm disorders are harmless, others can lead to severe complications.
male with pertinent past medical history including Atrialfibrillation, atrial flutter, cardiomyopathy, Pulmonary Embolism, and hypertension presented to the Emergency Department via ambulance for respiratory distress and tachycardia. He was noted to have irregular heartrhythm with rates 120-170s.
Atrialfibrillation is the most common cardiac arrhythmia that is encountered in clinical practice, with some 4.5% It has been nearly 30 years since Hassaguerre and colleagues discovered that atrialfibrillation was a triggered arrhythmia initiated by repetitive discharges originating from.
Research Highlights: In a large study of adults with implanted heart devices that detected short, symptomless bouts of irregular heartrhythm, known as subclinical atrialfibrillation, those who took the anti-clotting medication apixaban were 37% less.
In patients with device-detected atrialfibrillation and a prior stroke, oral anticoagulation increases bleeding without a clear reduction in stroke. This finding was presented by Prof. May 16–19.
It remains unclear what causes symptoms in patients with paroxysmal atrialfibrillation (AF). Patients undergoing catheter ablation for AF often experience resolution of symptoms even when AF recurs, suggesting symptoms are not solely due to the heartrhythm.
16, 2025 Primary results from the DEFINE AFib clinical study show the Medtronic LINQ family of insertable cardiac monitors (ICM), paired with a novel algorithm, were able to detect atrialfibrillation episodes and properly risk stratify patients as high risk prior to an AF-related healthcare utilization 80% of the time. 2024, May 15).
A brisk walking pace, and the amount of time spent at this speed, may lower the risk of heartrhythm abnormalities, such as atrialfibrillation, tachycardia (rapid heartbeat), and bradycardia (very slow heartbeat), finds research published online in the journal Heart.
It is with great pride that we announce the resounding success of ADN CoE' s AFib Ablation Training program, the second installment in our esteemed Ablation Series, held at the prestigious 9 Eylül University HeartRhythm Management Centre. Dr. Emin Evren Özcan and Assoc. Oguzhan Ekrem Turan. Oguzhan Ekrem Turan.
The Role of Wearable Technology in Heart Health Wearable tech is designed to monitor physiological data and provide actionable insights to users. For heart health, these devices use advanced sensors to track metrics like heart rate, blood oxygen levels, and even irregular heartrhythms.
Atrialfibrillation (AF) is the most common arrhythmia worldwide, with increasing prevalence resulting from improved awareness, increased life expectancy, and advances in detection technology.
Weight Loss Drug Linked with Reduced Need for Diuretics in Heart Failure Patients 7. Late-breaking Clinical Trial Results from FARADISE, admIRE Study and Advent Trial at HeartRhythm 2024 Highlight Pulsed Field Ablation Developments for AtrialFibrillation Treatment 8. Tenax Therapeutics Announces New U.S.
Atrialfibrillation often shortened to AFib is an irregular and often rapid heartrhythm that can lead to serious health complications. Here are some of the most common: Medication – Your doctor may prescribe medications like blood thinners to reduce the risk of blood clots and control heart rate and rhythm.
Titled "Real-world Data Affirms Safety and Effectiveness of Low/Zero Fluoroscopy AtrialFibrillation Ablation," the study was presented as a late-breaker at the 29th Annual International AF Symposium. Real-world Data Affirms Safety and Effectiveness of Low/Zero Fluoroscopy AtrialFibrillation Ablation [abstract].
A study in more than 15,000 people has found that physical fitness is linked with a lower likelihood of developing atrialfibrillation and stroke. Atrialfibrillation is the most common heartrhythm disorder, affecting more than 40 million people worldwide.
care pathways and to provide millions of Americans with the ability to just use their smartphone to obtain easy and accurate heartrhythm measurements. These measurements can enable the early detection and monitoring of heartrhythm conditions such as atrialfibrillation. and a specificity of 99.9%.1
Atrialfibrillation (AF) is the most common heartrhythm disorder in clinical practice. It worsens the quality of life of patients, leads to an increase in the mortality rate because of its association with a high risk of thromboembolic complications.
We organize all of the trending information in your field so you don't have to. Join thousands of users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content